"The US Food and Drug Administration (FDA) has approved lenvatinib (Lenvima, Eisai), in combination with everolimus, for the treatment of patients with advanced renal cell carcinoma who were previously treated with an anti-angiogenic ther"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
PRALATREXATE - INJECTION
COMMON BRAND NAME(S): Folotyn
USES: Pralatrexate is used to treat a certain type of cancer known as Peripheral T-Cell Lymphoma (PTCL). It is used when other drugs do not work or the cancer returns after treatment with other drugs. Pralatrexate works by killing cancer cells.
HOW TO USE: Read the Patient Information Leaflet available from your pharmacist before you start using pralatrexate and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
This medication is given by a health care professional in a clinic or hospital. It is injected into a vein, usually over 3 to 5 minutes, once a week for 6 weeks. Tell your doctor or nurse immediately if you notice redness, pain, or swelling during your injection.
Dosage is based on your body size, medical condition, and response to treatment, including side effects.
You should avoid contact with this medication on the skin. If this occurs, immediately wash with soap and water. If this medication gets in the eyes, rinse with water.
To get the most benefit from this medication, do not miss any doses. To help you remember, mark the days on the calendar when you need to receive the medication.
Your doctor may also direct you to take folic acid and give you vitamin B12 shots to help prevent mouth sores from pralatrexate treatment.
Additional Folotyn Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.